FdaApplication
NDA 022246
Identifiers
- fda_app_no: NDA022246
Properties
| Property | Value |
|---|---|
| applicant_name | SALIX PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2009-09-04 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METOZOLV ODT | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| METOZOLV ODT | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
2 products